Overview

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of Brivaracetam to support the submission file in the indication of adjunctive treatment in adolescents and adults with partial onset seizures.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Pharma
Treatments:
Brivaracetam